BrainBox touts patent for TBI-detecting biomarkers

2019 04 30 23 29 0302 Brain 400

Diagnostic company BrainBox Solutions said the U.S. Patent and Trademark Office will issue a patent to its licensor for detecting and monitoring traumatic brain injury (TBI) using its Astrocyte-Injury Defined (AID) biomarkers.

The patent expands the company's multimodality approach by adding a portfolio of biomarkers that have characteristics for diagnostics, such as extended kinetic profiles after injury and a strong correlation to subtle microvascular injuries that are more difficult to assess. The patent includes the AID biomarker aldolase C (ALDOC) or a trauma-specific breakdown product of ALDOC.

With these patented biomarkers and the company's neurocognitive testing capabilities, the aim is to provide objective evidence of TBI injury and to predict patient recovery.

Page 1 of 35
Next Page